VISIOPHARM A/S

VISIOPHARM A/S (CVR number: 26186676K) is a company from RUDERSDAL. The company reported a net sales of 112.1 mDKK in 2023, demonstrating a decline of -17.6 % compared to the previous year. The operating profit percentage was poor at -21.5 % (EBIT: -24.1 mDKK), while net earnings were -30.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -19.8 %, which can be considered poor and Return on Equity (ROE) was -102 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 19.9 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. VISIOPHARM A/S's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.